(Left to right) Technician JP Pang, Owen McCarty, Ph.D., a professor in the Department of Biomedical Engineering at OHSU, and Annachiara Mitrugno, Ph.D., a postdoctoral fellow in the Division of Hematology and Medical Oncology at OHSU, have published research revealing low doses of aspirin might eventually prove safe and effective for some types of cancer prevention. (OHSU)

First author Annachiara Mitrugno, Ph.D., a postdoctoral fellow in the Division of Hematology and Medical Oncology at OHSU, designed the project and performed much of the research. (OHSU)

Christopher Friend is Oregon government relations director with the American Cancer Society Cancer Action Network. 

A participant gives a thumbs-up during the 6th Annual NW Melanoma 5K Walk and Fun Run, May 20, 2017. All proceeds from the walk support the Melanoma Tissue Bank Consortium. (OHSU/Patrick Kinghorn)

The 2016 War on Skin Cancer Event, held at the Collaborative Life Sciences Building in Portland, May 21, 2016. (OHSU/Patrick Kinghorn)

Jeff Tyner, Ph.D., associate professor in the OHSU School of Medicine department of Cell, Developmental & Cancer Biology and researcher with the OHSU Knight Cancer Institute, Sept. 12, 2018. (OHSU/Kristyna Wentz-Graff)

Jeff Tyner, Ph.D., associate professor in the OHSU School of Medicine department of Cell, Developmental & Cancer Biology and researcher with the OHSU Knight Cancer Institute, Sept. 12, 2018. (OHSU/Kristyna Wentz-Graff)

Steven Mansoor, M.D., Ph.D., and colleagues have identified the inner workings of the P2X7 protein receptor, which is associated with inflammation, coronary artery disease, cancer, multiple sclerosis and more. (OHSU)